Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (242)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
63
2026
3082
4.180
Why?
Antibodies, Bispecific
7
2025
108
1.300
Why?
Hematopoietic Stem Cell Transplantation
8
2024
610
0.870
Why?
Leukemia, Plasma Cell
2
2020
35
0.790
Why?
Plasma Cells
7
2025
234
0.740
Why?
Immunotherapy, Adoptive
5
2024
163
0.660
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
123
0.650
Why?
Bone Marrow
10
2022
359
0.650
Why?
B-Cell Maturation Antigen
7
2025
101
0.640
Why?
Neoplasms, Plasma Cell
3
2024
35
0.600
Why?
Humans
72
2026
53230
0.580
Why?
Chromosome Deletion
2
2023
138
0.540
Why?
Gene Expression Profiling
11
2025
1112
0.530
Why?
Positron-Emission Tomography
5
2025
298
0.520
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.520
Why?
Diffusion Magnetic Resonance Imaging
4
2025
133
0.520
Why?
Neoplasm, Residual
7
2025
171
0.510
Why?
Aged
27
2026
10429
0.500
Why?
Prognosis
17
2025
2118
0.490
Why?
Tumor Suppressor Protein p53
2
2017
228
0.490
Why?
Clinical Trials as Topic
4
2022
466
0.490
Why?
Transplantation, Autologous
9
2024
488
0.480
Why?
Gene Expression Regulation, Neoplastic
6
2021
868
0.480
Why?
Proteasome Inhibitors
1
2016
104
0.450
Why?
Immunologic Factors
1
2016
117
0.450
Why?
Immunotherapy
1
2016
266
0.410
Why?
Translocation, Genetic
5
2021
266
0.400
Why?
Antibodies, Monoclonal
2
2022
477
0.400
Why?
Mutation
7
2022
1337
0.400
Why?
Neoplasm Proteins
4
2020
330
0.370
Why?
Aged, 80 and over
12
2026
3494
0.370
Why?
Neutropenia
2
2023
113
0.370
Why?
Survival Analysis
8
2024
659
0.360
Why?
Stem Cell Transplantation
4
2022
191
0.360
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.350
Why?
Neoplasms
2
2012
1334
0.350
Why?
Middle Aged
25
2026
13419
0.350
Why?
Lymphocytes
1
2012
146
0.350
Why?
Evolution, Molecular
2
2021
97
0.330
Why?
Cancer Vaccines
1
2011
79
0.330
Why?
Neoplasm Recurrence, Local
7
2024
647
0.330
Why?
Female
31
2026
28782
0.330
Why?
Cytokines
1
2012
627
0.290
Why?
Adult
21
2026
14534
0.290
Why?
Male
29
2026
27435
0.290
Why?
Tumor Microenvironment
3
2024
274
0.270
Why?
Hematologic Neoplasms
2
2022
101
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1043
0.270
Why?
Combined Modality Therapy
4
2024
640
0.250
Why?
Atrial Fibrillation
2
2022
197
0.250
Why?
Cytomegalovirus
1
2026
42
0.240
Why?
Cytomegalovirus Infections
1
2026
49
0.230
Why?
Virus Activation
1
2026
49
0.230
Why?
Disease Progression
7
2025
880
0.230
Why?
Fluorodeoxyglucose F18
4
2021
182
0.220
Why?
Proto-Oncogene Proteins B-raf
3
2020
78
0.220
Why?
Immunoglobulins, Intravenous
1
2025
64
0.220
Why?
Risk Factors
10
2026
4017
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.210
Why?
Retrospective Studies
10
2026
6819
0.210
Why?
Neoplasms, Second Primary
1
2024
75
0.200
Why?
Chromosomes, Human, Pair 1
2
2023
95
0.190
Why?
Paraproteinemias
1
2022
72
0.180
Why?
Drug Approval
1
2022
41
0.180
Why?
Immunoconjugates
1
2022
37
0.180
Why?
Osteolysis
1
2022
74
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
Lymphoma, B-Cell
1
2022
60
0.180
Why?
Recurrence
6
2024
694
0.180
Why?
Treatment Outcome
7
2022
5595
0.180
Why?
Epigenomics
1
2021
76
0.170
Why?
Patient Participation
1
2022
72
0.170
Why?
T-Lymphocytes
4
2024
321
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.160
Why?
Cell Cycle
1
2021
237
0.160
Why?
Practice Guidelines as Topic
1
2023
502
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Resorption
1
2022
304
0.160
Why?
Bone Diseases
1
2021
94
0.160
Why?
Chromosomal Instability
1
2019
16
0.150
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Disease-Free Survival
5
2019
466
0.150
Why?
Antigens, CD
1
2020
217
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Spleen
1
2019
166
0.140
Why?
Spinal Fractures
1
2018
37
0.140
Why?
Phosphotransferases
1
2018
18
0.140
Why?
Bacteremia
1
2019
87
0.140
Why?
Antineoplastic Agents
2
2024
1232
0.140
Why?
Adipocytes
1
2018
131
0.140
Why?
Brain Neoplasms
2
2011
319
0.130
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Retinoblastoma Binding Proteins
1
2017
11
0.130
Why?
Flow Cytometry
1
2018
400
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Pelvis
1
2017
66
0.130
Why?
Epigenesis, Genetic
1
2020
412
0.130
Why?
Cell Proliferation
4
2023
1031
0.130
Why?
Survival Rate
4
2020
949
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
110
0.120
Why?
Immunoglobulin Light Chains
1
2017
90
0.120
Why?
Clonal Evolution
1
2016
59
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Ubiquitin-Protein Ligases
1
2017
140
0.120
Why?
Gene Expression
1
2018
618
0.120
Why?
Transcriptome
3
2025
367
0.110
Why?
Animals
4
2024
13526
0.110
Why?
Cystatin M
2
2024
17
0.100
Why?
Cross-Sectional Studies
3
2023
1723
0.100
Why?
Cardiovascular Diseases
1
2017
501
0.090
Why?
Follow-Up Studies
3
2024
2318
0.090
Why?
Lymphoma, Non-Hodgkin
1
2011
58
0.090
Why?
Astrocytoma
1
2011
19
0.090
Why?
Disease Models, Animal
1
2016
1517
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
In Situ Hybridization, Fluorescence
2
2023
266
0.080
Why?
Glioma
1
2011
83
0.080
Why?
Genomics
2
2023
271
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Tumor Burden
2
2020
132
0.080
Why?
Remission Induction
2
2021
221
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
69
0.070
Why?
Histones
2
2021
318
0.070
Why?
Vaccination
1
2011
310
0.070
Why?
Transcription Factors
2
2023
571
0.070
Why?
Radiopharmaceuticals
2
2021
198
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Models, Biological
1
2011
737
0.070
Why?
Cell Differentiation
2
2022
681
0.070
Why?
Kaplan-Meier Estimate
2
2019
487
0.060
Why?
Imaging, Three-Dimensional
2
2017
145
0.060
Why?
Biopsy
2
2018
600
0.060
Why?
ROC Curve
1
2025
246
0.050
Why?
Arkansas
2
2021
2068
0.050
Why?
Killer Cells, Natural
1
2024
113
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
80
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
145
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
58
0.050
Why?
Antibodies
1
2024
147
0.050
Why?
Mice
2
2024
5982
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Signal Transduction
2
2021
1748
0.050
Why?
Patients
1
2022
52
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
United States Food and Drug Administration
1
2022
93
0.040
Why?
Dexamethasone
1
2024
429
0.040
Why?
Oncogenes
1
2021
61
0.040
Why?
Patient Selection
1
2023
273
0.040
Why?
Bone Marrow Transplantation
1
2022
110
0.040
Why?
Chromosome Aberrations
1
2023
297
0.040
Why?
Phylogeny
1
2022
231
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.040
Why?
Clone Cells
1
2021
76
0.040
Why?
Chromatin
1
2021
145
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
238
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Pyrimidines
1
2022
205
0.040
Why?
Aneuploidy
1
2020
17
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Protein Kinase Inhibitors
1
2022
233
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Cell Line, Tumor
1
2023
1470
0.040
Why?
Health Status Disparities
1
2022
221
0.040
Why?
Multivariate Analysis
1
2021
598
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
180
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
29
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Syndrome
1
2019
248
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
423
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Oncogene Proteins, Fusion
1
2018
62
0.030
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.030
Why?
Protein-Tyrosine Kinases
1
2018
87
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
Retinoblastoma Protein
1
2017
19
0.030
Why?
Fibroblast Growth Factors
1
2017
52
0.030
Why?
False Positive Reactions
1
2017
66
0.030
Why?
STAT3 Transcription Factor
1
2017
89
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
152
0.030
Why?
Glomerular Filtration Rate
1
2017
128
0.030
Why?
Bone and Bones
1
2021
501
0.030
Why?
Amino Acid Sequence
1
2018
563
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Sequence Analysis, DNA
1
2017
216
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
NF-kappa B
1
2018
327
0.030
Why?
Glycolysis
1
2016
76
0.030
Why?
Staphylococcal Infections
1
2019
271
0.030
Why?
DNA Methylation
1
2020
592
0.030
Why?
Models, Genetic
1
2016
169
0.030
Why?
Genomic Instability
1
2016
88
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
98
0.030
Why?
Logistic Models
1
2018
947
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
148
0.030
Why?
Melphalan
1
2016
180
0.030
Why?
Heart
1
2017
350
0.030
Why?
Algorithms
1
2018
667
0.030
Why?
Kidney Diseases
1
2017
230
0.030
Why?
Echocardiography
1
2017
409
0.030
Why?
Time Factors
1
2021
2991
0.030
Why?
Thalidomide
1
2016
378
0.030
Why?
Myocardium
1
2017
471
0.030
Why?
Disease Management
1
2015
187
0.030
Why?
Longitudinal Studies
1
2016
774
0.030
Why?
Risk Assessment
1
2018
1368
0.020
Why?
Dose-Response Relationship, Drug
1
2016
1367
0.020
Why?
Ifosfamide
1
2011
9
0.020
Why?
Dacarbazine
1
2011
11
0.020
Why?
Tomography, X-Ray Computed
1
2017
1180
0.020
Why?
Carboplatin
1
2011
57
0.020
Why?
Etoposide
1
2011
71
0.020
Why?
Fatal Outcome
1
2011
193
0.020
Why?
Treatment Failure
1
2011
119
0.020
Why?
United States
1
2022
5409
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Magnetic Resonance Imaging
1
2017
1583
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description